ImmuCell Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
ImmuCell Corporation (ICCC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 86.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2025-03-28
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-12-31 was 13.00K shares, a 7.14% decline year-over-year.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 52.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-12-31 was 14.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-09-30 was 0.00 shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 86.00K shares, a 29.51% decline from fiscal 2023.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 122.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2024-12-31 | 13.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 65.00K shares derived: sum of 2 quarters · filed 2025-03-28 | 86.00K shares 10-K · filed 2025-03-28 | |
| 2024-09-30 | 52.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 73.00K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 21.00K shares 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | 14.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 14.00K shares derived: sum of 2 quarters · filed 2025-03-28 | 122.00K shares 10-K · filed 2025-03-28 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 108.00K shares 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | 108.00K shares 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |